MLTX
$12.39
▲ +0.32%09/18 O 12.28 H 12.50 L 12.09 C 12.39 ▲ +0.32%
Vol 1.8M RS 2
Vol 1.8M RS 2
RS rating2
Now vs pivot (%)−41.00%
Tightening (ATR ratio)1.31×
Volume dry-up1.37×
Up/down volume, net-0.24
From 52-week high80%
played out
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX · Pharmaceutical Preparations · $1.1B
Falling back
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 5.6 weeks and fell 25% from its ceiling at its deepest. The pivot is $21.00, and the stock closed 41.0% below it. Its relative strength rating is 2.
Peers
Catalyst roadmap
- EarningstentativeLLY · competitorin 41dLLY reportsOct 29, 2026
- Earningstentativein 48dQuarterly earningsNov 5, 2026
Flagged by the market sweep
GappedTape · 2026-09-12
-5.1%
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
No headlines for this company in the last couple of weeks.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray